| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,548 |
13,078 |
$650K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,000 |
13,885 |
$614K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,393 |
4,831 |
$42K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
262 |
256 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,291 |
1,832 |
$20K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
315 |
272 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
795 |
527 |
$13K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,195 |
1,125 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
423 |
367 |
$9K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,409 |
1,122 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
732 |
690 |
$8K |
| 99233 |
Prolong inpt eval add15 m |
478 |
179 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,758 |
2,470 |
$4K |
| 99223 |
Prolong inpt eval add15 m |
106 |
96 |
$4K |
| 99215 |
Prolong outpt/office vis |
69 |
69 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
637 |
617 |
$3K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
629 |
270 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
91 |
88 |
$2K |
| 81002 |
|
953 |
913 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
19 |
12 |
$1K |
| 99350 |
Prolong home eval add 15m |
45 |
41 |
$865.37 |
| 87428 |
|
20 |
15 |
$771.60 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
27 |
24 |
$725.33 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17 |
17 |
$683.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,304 |
1,146 |
$584.79 |
| 90756 |
|
156 |
153 |
$584.72 |
| 0011A |
|
13 |
13 |
$384.00 |
| 82947 |
|
210 |
207 |
$308.00 |
| 99337 |
|
21 |
12 |
$271.58 |
| 99305 |
|
37 |
36 |
$222.40 |
| 99318 |
|
21 |
20 |
$134.26 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
29 |
26 |
$100.00 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
13 |
13 |
$53.90 |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
12 |
12 |
$42.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12 |
12 |
$9.88 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
347 |
340 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
2,512 |
2,397 |
$0.00 |
| 3044F |
|
472 |
462 |
$0.00 |
| 3072F |
|
107 |
105 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
128 |
117 |
$0.00 |
| 91301 |
|
32 |
29 |
$0.00 |
| 99080 |
|
2,373 |
1,136 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
3,799 |
3,636 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
2,136 |
2,054 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
2,540 |
2,435 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,470 |
2,352 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
234 |
227 |
$0.00 |
| 2022F |
|
220 |
215 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
175 |
171 |
$0.00 |
| 3045F |
|
14 |
13 |
$0.00 |